It's About Time
Tempus AI is a health technology company that applies artificial intelligence to genomic, clinical, and molecular data to enable precision medicine across oncology, neurology, cardiology, and radiology. Its platform includes genomic profiling, AI-powered diagnostics, real-world data products, and clinical trial matching for both healthcare providers and life sciences companies. Founded in 2015 by Eric Lefkofsky, Tempus went public on Nasdaq in 2024.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
AI cloud platform delivering full-stack infrastructure for model training, inference, and deploym...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
UiPath is an AI-enhanced end-to-end automation platform.
GPU cloud infrastructure provider purpose-built for AI workloads and high-performance computing
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
